22.56
22.56 (0.83%)
As of Mar 06, 2024
Cabaletta Bio, Inc. [CABA]
Source:
Company Overview
Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases.
Country | United States |
Headquarters | philadelphia, pennsylvania |
Phone Number | (267) 759-3100 |
Industry | manufacturing |
CEO | Steven Nichtberger |
Website | www.cabalettabio.com |